封面
市場調查報告書
商品編碼
1534252

全球心血管修復和重建設備市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global Cardiovascular Repair and Reconstruction Devices Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: | 出版商: Value Market Research | 英文 117 Pages | 商品交期: 最快1-2個工作天內

價格

全球心血管修復和重建設備市場需求預計將從2023年的43.9億美元達到2032年近73.3億美元的市場規模,2024-2032年研究期間的複合年成長率為5.86%。

心血管修復和重建設備包括一系列用於透過手術介入治療心血管疾病 (CVD) 的醫療工具和植入物。這些設備旨在修復或重建患病或受損的心臟瓣膜、動脈和其他心臟結構,恢復正常的心臟功能並改善整體心血管健康。這些設備旨在修復或重建受損或患病的心臟瓣膜、動脈和其他心臟結構,從而恢復正常的心臟功能並增強整體心血管健康。常見的裝置包括人工心臟瓣膜、支架、心律調節器、除顫器和心臟貼片。它們對於管理冠狀動脈疾病、心臟瓣膜缺陷、心律不整和先天性心臟缺陷等疾病至關重要,為患者提供治療和預防干涉措施的選擇,以減輕與心血管疾病相關的風險。

市場動態

心血管疾病的流行和醫療技術的進步推動了心血管修復和重建設備市場。由於人口老化和生活方式的改變,全球心血管疾病負擔日益加重,增加了對提供微創治療選擇和改善患者治療效果的創新設備的需求。設備材料、設計和植入技術方面的技術進步提高了設備性能、耐用性以及與患者生理的兼容性。此外,全球醫療保健支出和心血管護理基礎設施投資的增加為心血管修復和重建設備市場的擴張提供了巨大的成長機會。政府和醫療保健提供者優先考慮採用先進的心血管設備,以解決與心血管疾病管理和住院相關的不斷上升的醫療成本。此外,提高心血管疾病早期檢測意識和篩檢計畫也有助於市場成長。關於心血管設備使用的患者教育措施和醫生培訓也支持市場滲透率和採用率,特別是在心血管護理機會正在改善的新興市場。此外,醫療器材製造商、研究機構和醫療保健提供者之間的策略合作推動了心血管修復和重建領域的創新和產品開發。對研究和臨床試驗的投資以驗證新設備的功效和安全性,進一步刺激市場成長和多元化。然而,新型心血管設備嚴格的法規核准流程和報銷挑戰對心血管修復和重建設備的市場成長構成了障礙。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外,這些工具也對全球心血管修復和重建設備市場的各個細分市場進行了包容性評估。心血管修復和重建設備產業的成長和趨勢為本研究提供了整體方法。

市場區隔

心血管修復和重建設備市場報告的這一部分提供了國家和地區層面細分市場的詳細資料,從而幫助策略家確定相應產品或服務的目標人群以及即將到來的機會。

按產品分類

  • 心臟瓣膜修復
  • 心血管移植物(血管內支架移植、血液透析通路移植物、周邊血管移植物)
  • 心血管補片(依應用分類(心臟修補補片(心房中隔缺損、共心房、心內膜墊缺損、室間隔缺損、法洛氏四合症、縫線出血)、血管修補補片(頸動脈內膜切除術、肺靜脈異常連接、運輸)大血管的重建、門靜脈和腸系膜上靜脈的重建、其他)(依原料分類(合成補片、生物補片)

區域分析

本節涵蓋區域前景,重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲心血管修復和重建設備市場當前和未來的需求。此外,該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。心血管修復和重建設備市場的主要參與者包括美敦力、巴德周邊血管、泰爾茂心血管系統公司、WL Gore & Associates Inc.、Getinge AB、CryoLife Inc.、Edwards Lifesciences Corporation。本節包含競爭格局的整體視圖,包括各種策略發展,例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求,請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章:前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法
    • 市場研究過程
    • 市場研究方法論

第 2 章:執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章:心血管修復和重建設備 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按產品分類的市場吸引力分析
    • 市場吸引力分析:按地區

第 4 章:價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章:全球心血管修復與重建設備市場分析:按產品

  • 概述(按產品)
  • 按產品分類的歷史和預測資料分析
  • 心臟瓣膜修復
  • 心血管移植物(血管內支架移植、血液透析通路移植物、周邊血管移植物)
  • 心血管補片(依應用分類(心臟修補補片(心房中隔缺損、共心房、心內膜墊缺損、室間隔缺損、法洛氏四合症、縫線出血)、血管修補補片(頸動脈內膜切除術、肺靜脈異常連接、運輸)大血管的重建、門靜脈及腸系膜上靜脈的重建、其他)(依原料分類(合成補片、生物補片)

第 6 章:全球心血管修復與重建設備市場分析:依地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區按國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲按國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 7 章:心血管修復與重建設備公司的競爭格局

  • 心血管修復重建器材市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 8 章:公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Medtronic
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Bard Peripheral Vascular
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Terumo Cardiovascular Systems Corporation
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • WL Gore & Associates Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Getinge AB
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • CryoLife Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Edwards Lifesciences Corporation
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態

註 - 在公司概況中,財務詳細資訊和最新發展視情況而定,或對私人公司而言可能不包括在內

Product Code: VMR112115293

The global demand for Cardiovascular Repair and Reconstruction Devices Market is presumed to reach the market size of nearly USD 7.33 Billion by 2032 from USD 4.39 Billion in 2023 with a CAGR of 5.86% under the study period 2024-2032.

Cardiovascular repair and reconstruction devices encompass a range of medical tools and implants used to treat cardiovascular diseases (CVDs) through surgical interventions. These devices are designed to repair or rebuild diseased or damaged heart valves, arteries, and other cardiac structures, restoring normal heart function and improving overall cardiovascular health. These devices are created to mend or rebuild damaged or diseased heart valves, arteries, and other cardiac structures, thereby restoring normal heart function and enhancing overall cardiovascular health. Common devices include prosthetic heart valves, stents, pacemakers, defibrillators, and cardiac patches. They are essential in managing conditions such as coronary artery disease, heart valve defects, arrhythmias, and congenital heart defects, offering patients options for both therapeutic and preventive interventions to mitigate the risks associated with CVDs.

MARKET DYNAMICS

The propelling prevalence of cardiovascular diseases and advancements in medical technology drives the cardiovascular repair and reconstruction devices market. The growing global burden of CVDs, fuelled by aging populations and lifestyle changes, amplifies demand for innovative devices that offer minimally invasive treatment options and improved patient outcomes. Technological advancements in device materials, design, and implantation techniques enhance device performance, durability, and compatibility with patient physiology. Moreover, rising healthcare expenditures and investments in cardiovascular care infrastructure worldwide provide significant growth opportunities for the expansion of the cardiovascular repair and reconstruction devices market. Governments and healthcare providers prioritize adopting advanced cardiovascular devices to address the escalating healthcare costs associated with CVD management and hospitalizations. Furthermore, increasing awareness and screening programs for early detection of cardiovascular conditions contribute to market growth. Patient education initiatives and physician training in the use of cardiovascular devices also support market penetration and adoption rates, particularly in emerging markets where access to cardiovascular care is improving. Additionally, strategic collaborations between medical device manufacturers, research institutions, and healthcare providers drive innovation and product development in the cardiovascular repair and reconstruction sector. Investments in research and clinical trials to validate the efficacy and safety of new devices further stimulate market growth and diversification. However, stringent regulatory approval processes and reimbursement challenges for new cardiovascular devices pose barriers to market growth for cardiovascular repair and reconstruction devices.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Cardiovascular Repair and Reconstruction Devices. The growth and trends of Cardiovascular Repair and Reconstruction Devices industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Cardiovascular Repair and Reconstruction Devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Heart Valve Repair
  • Cardiovascular Grafts (Endovascular Stent Graft, Hemodialysis Access Graft, Peripheral Vascular Graft)
  • Cardiovascular Patches (by Application (Cardiac Repair Patches (Atrial Septal Defect, Common Atrium, Defects of The Endocardial Cushion, Ventricular Septal Defect, Tetralogy of Fallot, Suture Bleeding), Vascular Repair Patches (Carotid Endarterectomy, Anomalous Connection of The Pulmonary Veins, Transportation of The Great Vessels, Reconstruction of The Portal and Superior Mesenteric Veins, Others) (by Raw Material (Synthetic Patches, Biological Patches)

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Cardiovascular Repair and Reconstruction Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cardiovascular Repair and Reconstruction Devices market include Medtronic, Bard Peripheral Vascular, Terumo Cardiovascular Systems Corporation, W. L. Gore & Associates Inc., Getinge AB, CryoLife Inc., Edwards Lifesciences Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. CARDIOVASCULAR REPAIR AND RECONSTRUCTION DEVICES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL CARDIOVASCULAR REPAIR AND RECONSTRUCTION DEVICES MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data Analysis By Product
  • 5.3. Heart Valve Repair Historic and Forecast Sales By Regions
  • 5.4. Cardiovascular Grafts (Endovascular Stent Graft, Hemodialysis Access Graft, Peripheral Vascular Graft) Historic and Forecast Sales By Regions
  • 5.5. Cardiovascular Patches (by Application (Cardiac Repair Patches (Atrial Septal Defect, Common Atrium, Defects of The Endocardial Cushion, Ventricular Septal Defect, Tetralogy of Fallot, Suture Bleeding), Vascular Repair Patches (Carotid Endarterectomy, Anomalous Connection of The Pulmonary Veins, Transportation of The Great Vessels, Reconstruction of The Portal and Superior Mesenteric Veins, Others) (by Raw Material (Synthetic Patches, Biological Patches) Historic and Forecast Sales By Regions

6. GLOBAL CARDIOVASCULAR REPAIR AND RECONSTRUCTION DEVICES MARKET ANALYSIS BY GEOGRAPHY

  • 6.1. Regional Outlook
  • 6.2. Introduction
  • 6.3. North America Sales Analysis
    • 6.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 6.3.2 North America By Segment Sales Analysis
    • 6.3.3 North America By Country Sales Analysis
    • 6.3.4 United States Sales Analysis
    • 6.3.5 Canada Sales Analysis
    • 6.3.6 Mexico Sales Analysis
  • 6.4. Europe Sales Analysis
    • 6.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 6.4.2 Europe By Segment Sales Analysis
    • 6.4.3 Europe By Country Sales Analysis
    • 6.4.4 United Kingdom Sales Analysis
    • 6.4.5 France Sales Analysis
    • 6.4.6 Germany Sales Analysis
    • 6.4.7 Italy Sales Analysis
    • 6.4.8 Russia Sales Analysis
    • 6.4.9 Rest Of Europe Sales Analysis
  • 6.5. Asia Pacific Sales Analysis
    • 6.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 6.5.2 Asia Pacific By Segment Sales Analysis
    • 6.5.3 Asia Pacific By Country Sales Analysis
    • 6.5.4 China Sales Analysis
    • 6.5.5 India Sales Analysis
    • 6.5.6 Japan Sales Analysis
    • 6.5.7 South Korea Sales Analysis
    • 6.5.8 Australia Sales Analysis
    • 6.5.9 South East Asia Sales Analysis
    • 6.5.10 Rest Of Asia Pacific Sales Analysis
  • 6.6. Latin America Sales Analysis
    • 6.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 6.6.2 Latin America By Segment Sales Analysis
    • 6.6.3 Latin America By Country Sales Analysis
    • 6.6.4 Brazil Sales Analysis
    • 6.6.5 Argentina Sales Analysis
    • 6.6.6 Peru Sales Analysis
    • 6.6.7 Chile Sales Analysis
    • 6.6.8 Rest of Latin America Sales Analysis
  • 6.7. Middle East & Africa Sales Analysis
    • 6.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 6.7.2 Middle East & Africa By Segment Sales Analysis
    • 6.7.3 Middle East & Africa By Country Sales Analysis
    • 6.7.4 Saudi Arabia Sales Analysis
    • 6.7.5 UAE Sales Analysis
    • 6.7.6 Israel Sales Analysis
    • 6.7.7 South Africa Sales Analysis
    • 6.7.8 Rest Of Middle East And Africa Sales Analysis

7. COMPETITIVE LANDSCAPE OF THE CARDIOVASCULAR REPAIR AND RECONSTRUCTION DEVICES COMPANIES

  • 7.1. Cardiovascular Repair and Reconstruction Devices Market Competition
  • 7.2. Partnership/Collaboration/Agreement
  • 7.3. Merger And Acquisitions
  • 7.4. New Product Launch
  • 7.5. Other Developments

8. COMPANY PROFILES OF CARDIOVASCULAR REPAIR AND RECONSTRUCTION DEVICES INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Market Concentration Rate
  • 8.3. Medtronic
    • 8.3.1 Company Overview
    • 8.3.2 Company Revenue
    • 8.3.3 Products
    • 8.3.4 Recent Developments
  • 8.4. Bard Peripheral Vascular
    • 8.4.1 Company Overview
    • 8.4.2 Company Revenue
    • 8.4.3 Products
    • 8.4.4 Recent Developments
  • 8.5. Terumo Cardiovascular Systems Corporation
    • 8.5.1 Company Overview
    • 8.5.2 Company Revenue
    • 8.5.3 Products
    • 8.5.4 Recent Developments
  • 8.6. W. L. Gore & Associates Inc.
    • 8.6.1 Company Overview
    • 8.6.2 Company Revenue
    • 8.6.3 Products
    • 8.6.4 Recent Developments
  • 8.7. Getinge AB
    • 8.7.1 Company Overview
    • 8.7.2 Company Revenue
    • 8.7.3 Products
    • 8.7.4 Recent Developments
  • 8.8. CryoLife Inc.
    • 8.8.1 Company Overview
    • 8.8.2 Company Revenue
    • 8.8.3 Products
    • 8.8.4 Recent Developments
  • 8.9. Edwards Lifesciences Corporation
    • 8.9.1 Company Overview
    • 8.9.2 Company Revenue
    • 8.9.3 Products
    • 8.9.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Heart Valve Repair Market Sales By Geography (USD MN)
  • Cardiovascular Grafts (Endovascular Stent Graft, Hemodialysis Access Graft, Peripheral Vascular Graft) Market Sales By Geography (USD MN)
  • Cardiovascular Patches (by Application (Cardiac Repair Patches (Atrial Septal Defect, Common Atrium, Defects of The Endocardial Cushion, Ventricular Septal Defect, Tetralogy of Fallot, Suture Bleeding), Vascular Repair Patches (Carotid Endarterectomy, Anomalous Connection of The Pulmonary Veins, Transportation of The Great Vessels, Reconstruction of The Portal and Superior Mesenteric Veins, Others) (by Raw Material (Synthetic Patches, Biological Patches) Market Sales By Geography (USD MN)
  • Global Cardiovascular Repair and Reconstruction Devices Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Cardiovascular Repair and Reconstruction Devices Report
  • Market Research Process
  • Market Research Methodology
  • Global Cardiovascular Repair and Reconstruction Devices Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Heart Valve Repair Market Sales By Geography (USD MN)
  • Cardiovascular Grafts (Endovascular Stent Graft, Hemodialysis Access Graft, Peripheral Vascular Graft) Market Sales By Geography (USD MN)
  • Cardiovascular Patches (by Application (Cardiac Repair Patches (Atrial Septal Defect, Common Atrium, Defects of The Endocardial Cushion, Ventricular Septal Defect, Tetralogy of Fallot, Suture Bleeding), Vascular Repair Patches (Carotid Endarterectomy, Anomalous Connection of The Pulmonary Veins, Transportation of The Great Vessels, Reconstruction of The Portal and Superior Mesenteric Veins, Others) (by Raw Material (Synthetic Patches, Biological Patches) Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.